SCHEMBL26546709

SCHEMBL26546709

COc1ccc(CNC(=O)Nc2ccc(CC(=O)N3CCCC3)cc2)cc1

nearest known ligand 0.64

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.64
NPC1 O15118 2/20 0.62
RAB9A P51151 2/20 0.62
HDAC1 Q13547 1/20 0.59
HDAC6 Q9UBN7 1/20 0.59
MEN1 O00255 3/20 0.57
KMT2A Q03164 3/20 0.57
HTT P42858 1/20 0.57
L3MBTL1 Q9Y468 1/20 0.57
MAPT P10636 1/20 0.56
POLB P06746 2/20 0.56
NAMPT P43490 1/20 0.55
KDM4E B2RXH2 1/20 0.54
ROCK2 O75116 1/20 0.54
THRB P10828 1/20 0.53
GAA P10253 1/20 0.53
HPGD P15428 1/20 0.53
ALDH1A1 P00352 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26132373 0.99 SMN1; SMN2 (0.62) SMN1; SMN2NPC1RAB9AHDAC1HDAC6
SCHEMBL23747806 0.98 SMN1; SMN2 (0.64) SMN1; SMN2NPC1RAB9AHDAC1HDAC6
SCHEMBL23747484 0.90 SMN1; SMN2 (0.60) SMN1; SMN2NPC1RAB9AHDAC1HDAC6
SCHEMBL26558304 0.89 SMN1; SMN2 (0.57) SMN1; SMN2NPC1RAB9AHDAC1HDAC6
SCHEMBL26550269 0.89 SMN1; SMN2 (0.59) SMN1; SMN2NPC1RAB9AHDAC1HDAC6
SCHEMBL23747805 0.87 SMN1; SMN2 (0.62) SMN1; SMN2NPC1RAB9AHDAC1HDAC6
SCHEMBL26100573 0.87 SMN1; SMN2 (0.57) SMN1; SMN2NPC1RAB9AHDAC1HDAC6
SCHEMBL23747355 0.86 SMN1; SMN2 (0.61) SMN1; SMN2NPC1RAB9AHDAC1HDAC6
SCHEMBL23728210 0.86 SMN1; SMN2 (0.61) SMN1; SMN2NPC1RAB9AHDAC1HDAC6
SCHEMBL26100239 0.86 SMN1; SMN2 (0.61) SMN1; SMN2NPC1RAB9AHDAC1HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230133132-A1 NAMPT MODULATORS CYTOKINETICS, INC. 2023-05-04 US disclosed
US-20230133132-A1 NAMPT MODULATORS CYTOKINETICS, INC. 2023-05-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230133132-A1 NAMPT MODULATORS NAMPT, MC4R, SIRT1 SMN1; SMN2 1161/4885NPC1 463/4885RAB9A 807/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.